Skip to main content

Multiple Myeloma

Multiple Myeloma

Real-World Analysis of Treatment Patterns and Outcomes in Patients with MM by Cytogenetic Risk

Multiple Myeloma

Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1/2 Results from MonumenTAL-1

Multiple Myeloma

Systematic Review and Meta-Analysis Comparing Whole-Body MRI and FDG PET/CT in Evaluating Treatment Response in Multiple Myeloma

Multiple Myeloma

Isatuximab plus Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: ICARIA-MM Final OS Analysis

Multiple Myeloma

Daratumumab plus Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma: Long-Term Outcomes from MAIA

Multiple Myeloma

Patient and Caregiver Preferences for RRMM Treatment Should Be Considered Using Shared Decision-Making

Multiple Myeloma

Ciltacabtagene Autoleucel Shows Promising Results in Patients with Multiple Myeloma Who Have Experienced Early Clinical Relapse

Multiple Myeloma

Updated Results from IKEMA Demonstrate a Median PFS of Nearly 3 Years with Isa-Kd

Multiple Myeloma

Daratumumab + Cyclophosphamide, Bortezomib, and Dexamethasone Induction Followed by Daratumumab Maintenance Achieved Durable Responses in Patients with RRMM and NDMM

Multiple Myeloma

Addition of ASCT to Triplet Induction and Lenalidomide Maintenance to Progression: Results from the DETERMINATION Trial

1
2
3
4
5

Page 2 of 10
Results 11 - 20 of 98